Pfizer Loses PTAB Challenge To Antibody Drug Patents
The Patent Trial and Appeal Board on Wednesday upheld a Hoffman-La Roche Ltd. unit's patents for purifying antibodies used in medicine, rejecting contentions by Pfizer Inc. that the patents were invalid...To view the full article, register now.
Already a subscriber? Click here to view full article